Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06666764 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Normobaric Oxygen in AIS Transferred for EVT

Study acronym: AN-O2
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 2 to 112v4
  2. Primary endpoint revised
    • Secondary endpoints revised (11)
    v3
  3. Trial status: Not Yet Recruiting to Recruitingv2 Show 4 more changesShow less
    • Study sites: 1 to 2
    • Start date changed from estimate of Nov 5, 2024 to Dec 13, 2024
    • Eligibility criteria expanded, about 33 words
    • Secondary endpoints revised (11)
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The primary objective of this study is to estimate the efficacy and safety of NBO on 3-month functional outcome after acute ischemic stroke
Trial Details
NCT Number NCT06666764
Lead Sponsor Capital Medical University
Conditions
(from sponsor)		 Ischemic Stroke
Related terms Ischemic Stroke
Enrollment 1,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov